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1. INTRODUCTION {#ajmga61324-sec-0001}
===============

The 22q11.2 deletion syndrome (22q11.2DS) is a multisystem condition associated with deletions on chromosome 22q11.2. With a prevalence of approximately 1 in 3000 live births, it is the most prevalent microdeletion syndromes in humans (Devriendt, Fryns, Mortier, Van Thienen, & Keymolen, [1998](#ajmga61324-bib-0020){ref-type="ref"}; Scambler, [2000](#ajmga61324-bib-0059){ref-type="ref"}). The 22q11.2 deletion mostly occurs de novo, and in the majority of cases the size of the deletion is around 3 Mb (McDonald‐McGinn et al., [2015](#ajmga61324-bib-0042){ref-type="ref"}). Independent of deletion size, the 22q11.2DS phenotype is highly variable. Common features include neurodevelopmental disorders and major birth defects such as congenital heart defects and submucous cleft palate, in addition to later‐onset conditions such as obesity and Parkinson\'s disease (Bassett et al., [2011](#ajmga61324-bib-0004){ref-type="ref"}; Fung et al., [2015](#ajmga61324-bib-0026){ref-type="ref"}; Voll et al., [2017](#ajmga61324-bib-0065){ref-type="ref"}). Endocrine problems and neuropsychiatric disorders are common manifestations, with the lifetime prevalence of schizophrenia in 22q11.2DS estimated to be up to 41% in adults (Schneider et al., [2014](#ajmga61324-bib-0060){ref-type="ref"}).

Although many patients with 22q11.2DS receive antipsychotic treatment for psychotic disorders or behavioral problems, little is known about the safety and tolerability of antipsychotics in people with 22q11.2DS. Current guidelines recommend following treatment guidelines for nondeleted patients with schizophrenia (Bassett et al., [2011](#ajmga61324-bib-0004){ref-type="ref"}; Fung et al., [2010](#ajmga61324-bib-0027){ref-type="ref"}). However, given the high prevalence of comorbid conditions, additional measures to safeguard tolerability and safety of antipsychotics might be needed. To assess whether patients with 22q11.2DS are vulnerable to side effects of antipsychotic medication, we carried out a systematic review.

2. METHODS {#ajmga61324-sec-0002}
==========

2.1. Literature search {#ajmga61324-sec-0003}
----------------------

This systematic review was performed according to the Preferred Reporting for Systematic Reviews and Meta‐analysis (PRISMA) Statement (Moher et al., [2015](#ajmga61324-bib-0044){ref-type="ref"}). The literature search was conducted by two independent researchers (J.B. and L.G.) using PubMed (Medline), Embase, Cochrane Database of Systematic Reviews, and PsychINFO. Combinations of the following search terms were used: "22q11.2DS," "velocardiofacial syndrome," "DiGeorge syndrome," "Shprintzen syndrome," and "adverse event" and "antipsychotic" or "psychosis." The search had no year restrictions, and languages were restricted to Dutch, English, German, and French. See Supporting Information (Table [S1](#ajmga61324-supitem-0001){ref-type="supplementary-material"}) for an example search string. The search cut‐off date was December 7, 2018. Reference lists of the included studies were searched for cross‐references. After independent screening by J.B and L.G., consensus about which studies to include was reached between J.B, L.G., and J.Z.

2.2. Inclusion criteria {#ajmga61324-sec-0004}
-----------------------

Publications were included when the following inclusion criteria were met: (a) the paper reported on a trial, cohort study or case report with specific mention of adverse events related to antipsychotic use; (b) the study included one or more patients with a molecularly confirmed diagnosis of 22q11.2DS; (c) the study was published in a peer‐reviewed journal or conference book. Quality of the included studies was assessed independently by J.B. and L.G. using the Cochrane Risk of Bias tool for harm studies (Higgins & Altman, [2008](#ajmga61324-bib-0033){ref-type="ref"}) or the tool for evaluating the methodological quality of case reports and case series (Murad, Sultan, Haffar, & Bazerbachi, [2018](#ajmga61324-bib-0048){ref-type="ref"}), dependent on the type of study ([Table S2 and Table S3](#ajmga61324-supitem-0001){ref-type="supplementary-material"}, respectively).

3. RESULTS {#ajmga61324-sec-0005}
==========

A flow diagram of the literature search is depicted in Figure [1](#ajmga61324-fig-0001){ref-type="fig"}. After screening the titles and abstracts, the search yielded 77 articles that reported on adverse events associated with antipsychotic use in patients with 22q11.2DS. After reading the full text of these 77 articles, 40 publications fulfilled inclusion criteria of which 11 (reporting on 8 studies) described trials, cross‐sectional or cohort studies (see Table [1](#ajmga61324-tbl-0001){ref-type="table"} for descriptive information; Butcher, Fung, Cheung, et al., [2013](#ajmga61324-bib-0012){ref-type="ref"}; Butcher, Marras, Pondal, et al., [2014](#ajmga61324-bib-0015){ref-type="ref"}; Butcher, Fung, Fitzpatrick, Guna, Andrade, Lang, et al., [2015](#ajmga61324-bib-0013){ref-type="ref"}; Butcher, Fung, Fitzpatrick, Guna, Andrade, Lang, & Chow, [2015](#ajmga61324-bib-0014){ref-type="ref"}; Dori et al., [2017](#ajmga61324-bib-0021){ref-type="ref"}; Gothelf, [2015](#ajmga61324-bib-0030){ref-type="ref"}; Gothelf et al., [2015](#ajmga61324-bib-0032){ref-type="ref"}; Kawano et al., [2014](#ajmga61324-bib-0036){ref-type="ref"}; Verhoeven & Egger, [2015](#ajmga61324-bib-0064){ref-type="ref"}; Voll et al., [2017](#ajmga61324-bib-0065){ref-type="ref"}; Wither, Borlot, MacDonald, et al., [2017](#ajmga61324-bib-0066){ref-type="ref"}). None of the included studies were randomized or blinded in design. Additionally, 30 case reports (Aksu & Demirkaya, [2016](#ajmga61324-bib-0001){ref-type="ref"}; Angelopoulos et al., [2017](#ajmga61324-bib-0003){ref-type="ref"}; Biswas, Hands, & White, [2008](#ajmga61324-bib-0005){ref-type="ref"}; Boot, Butcher, van Amelsvoort et al., 2015; Borders, Suzuki, & Safani, [2017](#ajmga61324-bib-0010){ref-type="ref"}; Briegel, [2007](#ajmga61324-bib-0011){ref-type="ref"}; Butcher et al., [2014](#ajmga61324-bib-0015){ref-type="ref"}; Demily, Poisson, Thibaut, & Franck, [2017](#ajmga61324-bib-0019){ref-type="ref"}; Engebretsen, Kihldal, & Bakken, [2015](#ajmga61324-bib-0022){ref-type="ref"}; Faedda, Wachtel, Higgins, & Shprintzen, [2015](#ajmga61324-bib-0023){ref-type="ref"}; Farrell et al., [2018](#ajmga61324-bib-0024){ref-type="ref"}; Gagliano & Masi, [2009](#ajmga61324-bib-0028){ref-type="ref"}; Gladston & Clarke, [2005](#ajmga61324-bib-0029){ref-type="ref"}; Gothelf et al., [1999](#ajmga61324-bib-0031){ref-type="ref"}; Jacobson & Turkel, [2013](#ajmga61324-bib-0035){ref-type="ref"}; Kontoangelos, Maillis, Maltezou, Tsiori, & Papageorgiou, [2015](#ajmga61324-bib-0037){ref-type="ref"}; Kook et al., [2010](#ajmga61324-bib-0038){ref-type="ref"}; Krahn, Maraganore, & Michels, [1998](#ajmga61324-bib-0039){ref-type="ref"}; Le Page, [2006](#ajmga61324-bib-0041){ref-type="ref"}; Molebatsi & Olashore, [2018](#ajmga61324-bib-0045){ref-type="ref"}; Muller & Fellgiebel, [2008](#ajmga61324-bib-0047){ref-type="ref"}; O\'Hanlon, Ritchie, Smith, & Patel, [2003](#ajmga61324-bib-0051){ref-type="ref"}; Ohi et al., [2013](#ajmga61324-bib-0052){ref-type="ref"}; Perret et al., [2017](#ajmga61324-bib-0053){ref-type="ref"}; Praharaj & Sarkar, [2010](#ajmga61324-bib-0054){ref-type="ref"}; Ruhe, Qureshi, & Procaccini, [2018](#ajmga61324-bib-0056){ref-type="ref"}; Sachdev, [2002](#ajmga61324-bib-0058){ref-type="ref"}; Starling & Harris, [2008](#ajmga61324-bib-0062){ref-type="ref"}; Thomas, [2003](#ajmga61324-bib-0063){ref-type="ref"}; Yacoub & Aybar, [2007](#ajmga61324-bib-0068){ref-type="ref"}) were included, summarized in Table [2](#ajmga61324-tbl-0002){ref-type="table"}. One publication described both a cross‐sectional study and a case report (Butcher et al., [2014](#ajmga61324-bib-0015){ref-type="ref"}), and is therefore included in both Tables [1](#ajmga61324-tbl-0001){ref-type="table"} and [2](#ajmga61324-tbl-0002){ref-type="table"}. The most commonly reported symptoms that were potentially related to antipsychotic medication and that may have clinical implications were classified into the following categories: movement disorders, seizures, weight gain, cardiac side effects, and cytopenias. The main results for each of these categories are discussed separately. For a detailed overview see Table [2](#ajmga61324-tbl-0002){ref-type="table"}.

![Study attrition diagram \[Color figure can be viewed at <http://wileyonlinelibrary.com>\]](AJMG-179-2292-g001){#ajmga61324-fig-0001}

###### 

Overview of results from trials, cross‐sectional, and cohort studies

  Study                                                                                                                                                                                                                                                                                                                                                                                       Publication type             Research design                 Study objective                                                                                                                                                                      Population                                     Sample size (*N*)                                  Antipsychotic(s)                                          Results                                                               
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------- -------------------------------------------------- --------------------------------------------------------- --------- ----------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Butcher et al. ([2013](#ajmga61324-bib-0016){ref-type="ref"}), Butcher et al. ([2014](#ajmga61324-bib-0015){ref-type="ref"}), Butcher, Fung, Fitzpatrick, Guna, Andrade, Lang, et al. ([2015](#ajmga61324-bib-0013){ref-type="ref"}), and Butcher, Fung, Fitzpatrick, Guna, Andrade, Lang, & Chow ([2015](#ajmga61324-bib-0014){ref-type="ref"})[a](#ajmga61324-note-0002){ref-type="fn"}   Abstracts (3*x*) + article   Retrospective                   Assess whether patients 22q11.2DS schizophrenia show a different response profile to clozapine than those with idiopathic schizophrenia                                              Psychosis                                      Idiopathic psychosis                               20                                                        20        Clozapine                                                   Half of the 22q11.2DS group (*n* = 10, 50%) experienced at least one serious adverse; event compared with none of the idiopathic group (gender‐adjusted OR = 16.5, 95% CI 1.8--149.8), comprising myocarditis (*n* = 1, 5%), severe neutropenia (*n* = 3, 15%) and seizures (*n* = 8, 40%). Seizures occurred at lower doses (250--400 mg) in 22q11.2DS patients than in idiopathic schizophrenia, despite anticonvulsants in a significant proportion of the patients
  Dori, Green, Weizman, and Gothelf ([2017](#ajmga61324-bib-0021){ref-type="ref"})                                                                                                                                                                                                                                                                                                            Article                      Retrospective                   Evaluate the effectiveness and safety of antipsychotic and antidepressant medications in individuals with 22q11.2DS and psychiatric comorbidity                                      Psychosis                                      --                                                 19 (35 trials)[b](#ajmga61324-note-0003){ref-type="fn"}   --        Risperidone/olanzapine/quetiapine                           Akathisia/parkinsonism (*n* = 9, 25.7%), weight gain (*n* = 5, 14%), drowsiness (*n* = 3, 8.7%), decreased appetite (*n* = 3, 8.7%), convulsions (*n* = 2, 5.7%), hyperprolactinemia and menstrual irregularities (*n* = 2, 5.7%), hyper salivation (*n* = 1, 2.9%), tics (*n* = 1, 2.9%), QT prolongation (*n* = 1, 2.9%), elevated liver enzymes (*n* = 1, 2.9%)
  Gothelf ([2015](#ajmga61324-bib-0030){ref-type="ref"})[c](#ajmga61324-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                             Abstract                     Prospective                     Assess the safety and effectiveness of psychiatric medications in 22q11.2DS                                                                                                          Children and young adults                      --                                                 86                                                        --        n.s.                                                        Similar type and frequency of adverse events as in those reported in non‐22q11.2DS individuals using antipsychotics
  Gothelf et al. ([2015](#ajmga61324-bib-0032){ref-type="ref"})[c](#ajmga61324-note-0004){ref-type="fn"}                                                                                                                                                                                                                                                                                      Abstract                     Prospective                     Identify the phenotypic markers that are unique to 22q11.2DS and those associated with psychosis‐risk. Assess the safety and effectiveness of psychiatric medications in 22q11.2DS   Children and young adults                      Children and young adults with Williams syndrome   100                                                       50        n.s.                                                        Similar type and frequency of adverse events as in those reported in non‐22q11.2DS individuals using antipsychotics
  Kawano, Oshimo, Hasegawa, and Ishigooka ([2014](#ajmga61324-bib-0036){ref-type="ref"})                                                                                                                                                                                                                                                                                                      Abstract                     Open‐label trial                Assess the safety and efficacy of aripiprazole in 22q11.2DS ASD                                                                                                                      ASD                                            --                                                 3                                                         --        Aripiprazole                                                No adverse effects
  Verhoeven and Egger ([2015](#ajmga61324-bib-0064){ref-type="ref"})                                                                                                                                                                                                                                                                                                                          Article                      Retrospective and prospective   Assess the efficacy of antipsychotics in 22q11.2DS and propose an appropriate psychopharmacological strategy                                                                         Adult and adolescent patients with psychosis   --                                                 28                                                        --        Clozapine/quetiapine/risperidone/haloperidol/aripiprazole   No major side effects
  Voll et al. ([2017](#ajmga61324-bib-0065){ref-type="ref"})                                                                                                                                                                                                                                                                                                                                  Article                      Cross‐sectional                 Characterize the prevalence of and contributing factors to adult obesity 22q11.2DS                                                                                                   Adult patients                                 --                                                 207                                                       --        n.s.                                                        Results for psychotropic medication use (including but not exclusively antipsychotics) and obesity: OR = 2.60
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Wither et al. ([2017](#ajmga61324-bib-0067){ref-type="ref"})                                                                                                                                                                                                                                                                                                                                Article                      Retrospective                   Investigate the prevalence and characteristics of seizures and epilepsy in adult 22q11.2DS                                                                                           Adult patients                                 --                                                 202                                                       --        n.s.                                                        32 (15.8%) had a documented history of seizures. Of these 145 (71.8%) had acute symptomatic seizures, usually associated with hypocalcemia and/or antipsychotic or antidepressant use

Abbreviations: ASD, autism spectrum disorder; mg, milligram, n.s., not specified; −, not present.

These articles described the same study population and are therefore reported together here.

This study describes 19 patients that received a total of 35 trials with an antipsychotic.

These articles describe partly overlapping cohorts.

###### 

Overview of results from case reports

  Study                                                                                                         Publication type                                Sex                                                            Age                                                                                         Intellectual functioning                                                                                                       History of seizures                                      Relevant comorbidities                                                                                                                                                                          Psychiatric disorder(s)                                                         Medication regime                                                                                                                                                                                                                                                                                                           
  ------------------------------------------------------------------------------------------------------------- ----------------------------------------------- -------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------
  Aksu and Demirkaya ([2016](#ajmga61324-bib-0001){ref-type="ref"})                                             Article                                         F                                                              15                                                                                          IQ 48                                                                                                                          Hypocalcemic convulsions                                 Thymus aplasia, hypoparathyroidism, hypocalcemia, kidney aplasia                                                                                                                                Sz                                                                              1                                                         Clozapine 500 mg                                                                                           --                                                                                                                                                     Generalized tonic--clonic convulsion
  2                                                                                                             Clozapine 250 mg                                Valproic acid 500 mg                                           Mild sedation, sialorrhea                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Angelopoulos et al. ([2017](#ajmga61324-bib-0003){ref-type="ref"})                                            Article                                         M                                                              19                                                                                          IQ 50                                                                                                                          --                                                       Cardiomegaly, bilateral basal ganglia calcifications                                                                                                                                            Sz                                                                              1                                                         Risperidone 20 mg                                                                                          Biperiden 6 mg, Topiramate 100 mg                                                                                                                      Gaps in memory, dizzy
  2                                                                                                             Olanzapine 50 mg                                Clonazepam 2 mg                                                Gaps in memory                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  3                                                                                                             Haloperidol 60 mg, olanzapine 20 mg             Biperiden 6 mg, clonazepam 2 mg                                Gaps in memory                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  4                                                                                                             Clozapine 300 mg                                Clonazepam 1 mg                                                --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Biswas et al. ([2008](#ajmga61324-bib-0005){ref-type="ref"})                                                  Article                                         F                                                              34                                                                                          Mild ID                                                                                                                        --                                                       Musculo‐skeletal abnormalities                                                                                                                                                                  Depression, borderline personality disorder, psychosis                          1                                                         Clozapine dose NR                                                                                          --                                                                                                                                                     Hyper salivation
  Boot et al. (2015)                                                                                            Article                                         M                                                              45                                                                                          Moderate to severe ID                                                                                                          --                                                       --                                                                                                                                                                                              Sz                                                                              1                                                         Quetiapine 700 mg                                                                                          --                                                                                                                                                     Seizures and oculogyric crisis
  2                                                                                                             Aripiprazole 15 mg                              --                                                             Generalized epileptic seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  3                                                                                                             Clozapine 150 mg                                --                                                             Myoclonus, cogwheel rigidity, rest tremors bilaterally                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  M                                                                                                             54                                              Mild ID                                                        --                                                                                          Tardive dyskinesia as a result of previous antipsychotic treatments                                                            Sz                                                       1                                                                                                                                                                                               Clozapine 300 mg                                                                Benztropine 2 mg                                          Myoclonic jerks, seizure                                                                                                                                                                                                                                          
  2                                                                                                             Clozapine 200 mg                                Clonazepam 3 mg                                                Hand tremor                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  3                                                                                                             Clozapine 400 mg                                Benztropine                                                    Tonic--clonic seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  4                                                                                                             Clozapine dose NR                               Gabapentin 3,000 mg, clonazepam 1.5 mg, calcium, vitamin D     Rest tremor                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  M                                                                                                             38                                              Mild ID                                                        --                                                                                          --                                                                                                                             Sz                                                       1                                                                                                                                                                                               Olanzapine 17.5 mg                                                              Fluoxetine 20 mg, domperidone 40 mg, calcium, vitamin D   Decreased facial expression, slowness, rigidity, decrease in restlessness, periodic oculogyric movements                                                                                                                                                          
  Borders et al. ([2017](#ajmga61324-bib-0010){ref-type="ref"})                                                 Article                                         F                                                              34                                                                                          IQ 87                                                                                                                          --                                                       Right aortic arch, cerebellar cyst, scoliosis, hypocalcaemia                                                                                                                                    ASD, sz, generalized anxiety disorder, panic disorder                           1                                                         Quetiapine dose NR                                                                                         --                                                                                                                                                     Sedation
  2                                                                                                             Aripiprazole dose NR                            --                                                             Shaking and claw‐like spasms                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  3                                                                                                             Asenapine 10 mg                                 Clonazepam 1 mg                                                Dystonic reactions, including shaking and claw‐like spasms of the hand                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Briegel ([2007](#ajmga61324-bib-0011){ref-type="ref"})                                                        Abstract                                        M                                                              10                                                                                          --                                                                                                                             --                                                       --                                                                                                                                                                                              Sz                                                                              1                                                         Clozapine dose NR                                                                                          --                                                                                                                                                     Seizure
  Butcher et al. ([2014](#ajmga61324-bib-0015){ref-type="ref"})                                                 Abstract                                        M                                                              54                                                                                          --                                                                                                                             --                                                       --                                                                                                                                                                                              Sz                                                                              1                                                         Clozapine dose NR                                                                                          --                                                                                                                                                     Progressive parkinsonism (including bradykinesia, rigidity, and right‐sided tremor) and myoclonus
  Demily et al. ([2017](#ajmga61324-bib-0019){ref-type="ref"})                                                  Article                                         M                                                              37                                                                                          --                                                                                                                             --                                                       --                                                                                                                                                                                              Sz                                                                              1                                                         Quetiapine 300 mg                                                                                          --                                                                                                                                                     Weight loss
  Engebretsen et al. ([2015](#ajmga61324-bib-0022){ref-type="ref"})                                             Article                                         F                                                              19                                                                                          --                                                                                                                                                                                      Graves\' disease                                                                                                                                                                                Schizoaffective disorder                                                        1                                                         Olanzapine dose NR                                                                                                                                                                                                                                                Weight gain, increased blood sugar, leukopenia
  2                                                                                                             Ziprasidone dose NR                             --                                                             --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  3                                                                                                             Aripiprazole dose NR                            --                                                             --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  4                                                                                                             Amisulpride dose NR                             --                                                             Unspecified severe side effects                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  5                                                                                                             Quetiapine dose NR                              --                                                             Tiredness                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  6                                                                                                             Haloperidol dose NR                             --                                                             Weight loss, compulsions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  7                                                                                                             Clozapine dose NR                               --                                                             Severe tremor, leukopenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  8                                                                                                             Risperidone dose NR                             --                                                             --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Faedda et al. ([2015](#ajmga61324-bib-0023){ref-type="ref"})                                                  Article                                         F                                                              15                                                                                          IQ 58                                                                                                                          --                                                       Asthma                                                                                                                                                                                          Possible ADHD, anxiety disorder NOS                                             1                                                         Olanzapine 15 mg                                                                                           Lorazepam 12 mg                                                                                                                                        Weight gain (30 pounds in 3 months)
  2                                                                                                             Ziprasidone 120 mg                              --                                                             Body aches and tight throat with swallowing problems                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Farrell et al. ([2018](#ajmga61324-bib-0024){ref-type="ref"})                                                 Article                                         M                                                              41                                                                                          IQ 80                                                                                                                          --                                                       Huntington\'s disease, hyperkinetic movement disorder (oro‐lingual‐buccal dyskinesia, choreoathetosis, mingled with repetitive grabbing movements, and posturing of the left upper extremity)   Sz                                                                              1                                                         Perphenazine dose NR                                                                                       Lithium                                                                                                                                                --
  2                                                                                                             Perphenazine, olanzapine, clozapine; doses NR   --                                                             Thrombocytopenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  3                                                                                                             Clozapine dose NR                               --                                                             Obesity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  4                                                                                                             Clozapine, Risperidone; doses NR                Fluoxetine                                                     Thrombocytopenia, obesity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  5                                                                                                             Clozapine, Ziprasidone dose NR                  --                                                             --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Gagliano and Masi ([2009](#ajmga61324-bib-0028){ref-type="ref"})                                              Article                                         F                                                              7                                                                                           --                                                                                                                                                                                      Idiopathic precocious puberty, high levels of B‐humanchorionic gonadotropin and estradiol                                                                                                       Sz                                                                              1                                                         Risperidone 1.5 mg, Aripiprazole 7.5 mg                                                                    --                                                                                                                                                     Mild and transient nausea
  2                                                                                                             Clozapine 150 mg, Aripiprazole 8.7 mg           Tamoxifen 10 mg                                                Psychomotor agitation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  3                                                                                                             Clozapine 150 mg, Aripiprazole 10 mg            Valproic 900 mg, Tamoxifen 10 mg                               Neutropenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  4                                                                                                             Clozapine 150 mg, Aripiprazole 15 mg            Lithium 600 mg, Tamoxifen 10 mg                                Sedation, enuresis, increased appetite                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  5                                                                                                             Clozapine 200 mg, Aripiprazole 15 mg            Lithium 600 mg, Tamoxifen 10 mg                                Weight gain, tachycardia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  Gladston and Clarke ([2005](#ajmga61324-bib-0029){ref-type="ref"})                                            Article                                         M                                                              32                                                                                          IQ 66                                                                                                                          --                                                       Palate abnormality                                                                                                                                                                              Schizoaffective disorder                                                        1                                                         Clozapine 300 mg                                                                                           --                                                                                                                                                     Hypersalivation, constipation, myoclonic‐epilepsy
  2                                                                                                             Clozapine 300 mg                                Sodium valproate 300 mg                                        Myoclonic jerks                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  3                                                                                                             Clozapine 300 mg                                Sodium valproate 1,200 mg                                      --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Gothelf et al. ([1999](#ajmga61324-bib-0031){ref-type="ref"})                                                 Article                                         F                                                              35                                                                                          --                                                                                                                                                                                                                                                                                                                                                                                      Psychosis                                                                       1                                                         Clozapine 200 mg                                                                                           Valproate 600 mg                                                                                                                                       Unspecified myoclonic jerks
  Jacobson and Turkel ([2013](#ajmga61324-bib-0035){ref-type="ref"})[a](#ajmga61324-note-0006){ref-type="fn"}   Article                                         F                                                              2                                                                                           --                                                                                                                             A prior seizure                                          Congenital heart defect, recurrent pneumonia, pulmonary hypertension, and right heart failure, recently developed choreiform movements                                                          Delirium                                                                        1                                                         Fluphenazine dose NR                                                                                       Fentanyl, midazolam, Lorazepam, chloral hydrate, Vecuronium, transdermal clonidine, diphenhydramine, Pressors, anticoagulants, diuretics, sildenafil   Elevated liver enzymes
  Kontoangelos et al. ([2015](#ajmga61324-bib-0037){ref-type="ref"})                                            Article                                         M                                                              18                                                                                          --                                                                                                                             --                                                                                                                                                                                                                                                       Behavioral disorders                                                            1                                                         Haloperidol 2 mg                                                                                           --                                                                                                                                                     Cervical dystonia, torticollis, continuous twisting movements of the trunk and limbs, dysarthria
  2                                                                                                             Quetiapine 200 mg                                                                                              --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Kook et al. ([2010](#ajmga61324-bib-0038){ref-type="ref"})                                                    Article                                         F                                                              25                                                                                          --                                                                                                                                                                                      Hypothyroidism, hypoparathyroidism                                                                                                                                                              Sz                                                                              1                                                         Risperidone 8 mg                                                                                           Levothyroxine and vitamin D                                                                                                                            Generalized tonic--clonic seizures
  Krahn et al. ([1998](#ajmga61324-bib-0039){ref-type="ref"})                                                   Article                                         M                                                              27                                                                                          IQ 70                                                                                                                          --                                                       Ventricular septal defect and persistent ductus arteriosus, Parkinson\'s disease                                                                                                                Sz                                                                              1                                                         Fluphenazine (decanoate)                                                                                   --                                                                                                                                                     Muscle rigidity, oral‐buccal movements, tremors of tongue and upper extremities, drug‐induced parkinsonism
  2                                                                                                             Clozapine 125 mg                                Levocarbidopa 100/25 mg, amantadine 100 mg, Benztropine 2 mg   Resting tremor of all limbs, generalized bradykinesia, generalized tonic--clonic seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Le Page ([2006](#ajmga61324-bib-0041){ref-type="ref"})                                                        Article                                         F                                                              17                                                                                          Borderline intellectual functioning                                                                                            --                                                                                                                                                                                                                                                       Psychosis                                                                       1                                                         Clozapine dose NR                                                                                          --                                                                                                                                                     Agranulocytosis
  2                                                                                                             Haloperidol dose NR                             Sodium valproate                                               Thrombocytopenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Molebatsi and Olashore ([2018](#ajmga61324-bib-0045){ref-type="ref"})                                         Article                                         F                                                              13                                                                                          --                                                                                                                                                                                      Complex congenital heart defect                                                                                                                                                                 Sz                                                                              1                                                         Haloperidol 3 mg                                                                                           --                                                                                                                                                     Akathisia, sialorrhea
  2                                                                                                             Olanzapine 5 mg                                 --                                                             --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Muller and Fellgiebel ([2008](#ajmga61324-bib-0047){ref-type="ref"})                                          Article                                         F                                                              41                                                                                          Mild ID                                                                                                                        --                                                       Bilateral hearing loss, ventricular tachycardia                                                                                                                                                 Psychosis                                                                       1                                                         Quetiapine 400 mg                                                                                          --                                                                                                                                                     --
  O\'Hanlon et al. ([2003](#ajmga61324-bib-0051){ref-type="ref"})                                               Article                                         F                                                              23                                                                                          Mild ID                                                                                                                                                                                 Right bundle‐branch block, lymphopenia, thrombocyto‐penia                                                                                                                                       Psychosis                                                                       Previous trials                                           Haloperidol, Thiothixene, Risperidone, Thioridazine, olanzapine, Quetiapine; doses NR                      --                                                                                                                                                     Hypertension, seizure disorder
  1                                                                                                             Thioridazine 50 mg                              Propranolol 20 mg, Bromocriptine 2.5 mg, phenytoin 200 mg      --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  2                                                                                                             Olanzapine 30 mg                                Propranolol 20 mg, Bromocriptine 2.5 mg, phenytoin 200 mg      Worsening of chronic thrombocytopenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Ohi et al. ([2013](#ajmga61324-bib-0052){ref-type="ref"})                                                     Article                                         F                                                              48                                                                                          IQ 80                                                                                                                                                                                   Thymic hypoplasia, hypocalcemia bilateral basal ganglia calcifications, thrombocytopenia                                                                                                        Sz                                                                              1                                                         Risperidone 1,200 mg                                                                                       --                                                                                                                                                     Generalized spasm
  Perret et al. ([2017](#ajmga61324-bib-0053){ref-type="ref"})                                                  Article                                         F                                                              27                                                                                          IQ 100                                                                                                                                                                                  Multiple congenital malformations                                                                                                                                                               Bipolar disorder type 1, psychotic episode                                      1                                                         Olanzapine 10 mg                                                                                           --                                                                                                                                                     Weight gain, tremor, unspecified dystonia
  2                                                                                                             Risperidone dose NR                             --                                                             Weight gain, tremor, unspecified dystonia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Praharaj and Sarkar ([2010](#ajmga61324-bib-0054){ref-type="ref"})                                            Article                                         M                                                              21                                                                                          IQ 85                                                                                                                                                                                   Bifascicular block, ventricular ejection fraction 63%                                                                                                                                           Predominantly manic symptoms                                                    1                                                         Olanzapine 20 mg                                                                                           Sodium valproate 2 mg                                                                                                                                  Thrombocytopenia
  2                                                                                                             Clozapine 300 mg                                ‐                                                              Thrombocytopenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Ruhe et al. ([2018](#ajmga61324-bib-0056){ref-type="ref"})                                                    Article                                         M                                                              17                                                                                          --                                                                                                                             --                                                       Hypothyroidism                                                                                                                                                                                  Bipolar disorder, schizophrenia or schizoaffective disorder                     1                                                         Clozapine 175 mg                                                                                           Cariprazine 6 mg                                                                                                                                       Mild diarrhea, thrombocytopenia, neck stiffness, sore throat, myocarditis
  Levothyroxine 100 mg                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Sachdev ([2002](#ajmga61324-bib-0058){ref-type="ref"})                                                        Article                                         M                                                              22                                                                                          Mild to moderate ID                                                                                                            Epileptic seizures                                       --                                                                                                                                                                                              Psychotic disorder                                                              1                                                         Chlorpromazine 100 mg                                                                                      --                                                                                                                                                     Drowsiness, hypotension
  2                                                                                                             Olanzapine 10 mg                                --                                                             Tremulous, hypotension, myoclonus of the limbs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Starling and Harris ([2008](#ajmga61324-bib-0062){ref-type="ref"})                                            Article                                         F                                                              16                                                                                          Moderate ID                                                                                                                    Epilepsy with myoclonic jerks and generalized seizures   Ventricular septal defect, poor motor skills, cortical, and cerebellar atrophy                                                                                                                  Repetitive behavior, angry outbursts, depressed mood, auditory hallucinations   1                                                         Olanzapine 7.5 mg                                                                                          --                                                                                                                                                     Weight gain
  2                                                                                                             Aripiprazole 20 mg                              Sodium valproate 800 mg                                        Neuroleptic malignant syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  F                                                                                                             15                                              --                                                             --                                                                                          Gray matter heterotopia frontal horn of the lateral ventricles bilaterally, hyperdense foci in right frontal horn on MRI       Depressed mood, paranoid delusions, and hallucinations   1                                                                                                                                                                                               Olanzapine 20 mg                                                                Fluvoxamine 50 mg                                         Weight gain                                                                                                                                                                                                                                                       
  M                                                                                                             18                                              --                                                                                                                                                         Congenital hypoparathyroidism, pulmonary artery stenosis, hyperdense foci in frontal lobes, and basal ganglia on cerebral CT   Psychosis                                                1                                                                                                                                                                                               Quetiapine 800 mg                                                               --                                                        Sedation, weight gain                                                                                                                                                                                                                                             
  2                                                                                                             Amisulpride 1,000 mg                            --                                                             Unspecified dystonia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  3                                                                                                             Olanzapine 30 mg                                --                                                             Sedation, weight gain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Thomas ([2003](#ajmga61324-bib-0063){ref-type="ref"})                                                         Article                                         M                                                              23                                                                                          ID                                                                                                                             --                                                       --                                                                                                                                                                                              Psychosis                                                                       1                                                         Risperidone 2 mg                                                                                           Calcium                                                                                                                                                Psychomotor retardation
  Yacoub and Aybar ([2007](#ajmga61324-bib-0068){ref-type="ref"})                                               Article                                         F                                                              25                                                                                          Borderline intellectual functioning                                                                                            --                                                       Prominence of the lateral ventricles                                                                                                                                                            Psychosis                                                                       1                                                         Clozapine 150 mg                                                                                           --                                                                                                                                                     Mild sedation, hyper salivation, tonic--clonic seizure
  2                                                                                                             Clozapine 75 mg                                 Divalproex sodium 750 mg                                       --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

Abbreviations: -- = not reported/not present, mg = milligram, F = female, M = male, sz = schizophrenia, ASD = autism spectrum disorder, \# = number, NR = not reported, ID = intellectual disability.

This case report describes a 2‐year‐old with recurrent pneumonia, a prior seizure, pulmonary hypertension, and right heart failure. The child underwent surgical repair of congenital cardiac defects. Psychiatrists were consulted to assist with managing the delirium while she was intubated and sedated.

3.1. Movement disorders {#ajmga61324-sec-0006}
-----------------------

Extrapyramidal symptoms were frequently reported in individuals with 22q11.2DS treated with antipsychotics. In 19 patients who together received 35 trials with risperidone, olanzapine, and quetiapine (Dori et al., [2017](#ajmga61324-bib-0021){ref-type="ref"}), extrapyramidal symptoms were reported in nine of the 35 (25.7%) trials. No information was provided on whether extrapyramidal symptoms occurred more often during treatment with either risperidone, olanzapine or quetiapine. The severity or the type of motor symptoms was also not reported. Notably, although clozapine is generally considered to be practically free of motor side effects (Casey, [1989](#ajmga61324-bib-0018){ref-type="ref"}; Rummel‐Kluge et al., [2010](#ajmga61324-bib-0057){ref-type="ref"}), several case studies reported extrapyramidal symptoms in patients on monotherapy with clozapine (Boot, Butcher, van Amelsvoort, et al., [2015](#ajmga61324-bib-0009){ref-type="ref"}; Gagliano & Masi, [2009](#ajmga61324-bib-0028){ref-type="ref"}; Gladston & Clarke, [2005](#ajmga61324-bib-0029){ref-type="ref"}; Krahn et al., [1998](#ajmga61324-bib-0039){ref-type="ref"}; Ruhe et al., [2018](#ajmga61324-bib-0056){ref-type="ref"}), see Table [2](#ajmga61324-tbl-0002){ref-type="table"}. Noteworthy, there was one case report of a 27‐year‐old man with increasing parkinsonism (including bradykinesia, rigidity, and rest tremor) while on clozapine treatment (Krahn et al., [1998](#ajmga61324-bib-0039){ref-type="ref"}). The progressive nature of his symptoms however suggested that these symptoms were not primarily drug induced. Myoclonus was reported in several case reports under clozapine (Boot, Butcher, van Amelsvoort, et al., [2015](#ajmga61324-bib-0009){ref-type="ref"}; Butcher et al., [2014](#ajmga61324-bib-0015){ref-type="ref"}; Gladston & Clarke, [2005](#ajmga61324-bib-0029){ref-type="ref"}; Gothelf et al., [1999](#ajmga61324-bib-0031){ref-type="ref"}), and in one case under olanzapine treatment (Sachdev, [2002](#ajmga61324-bib-0058){ref-type="ref"}). Dystonia was reported during treatment with amisulpride (Starling & Harris, [2008](#ajmga61324-bib-0062){ref-type="ref"}), haloperidol (Kontoangelos et al., [2015](#ajmga61324-bib-0037){ref-type="ref"}), risperidone (Perret et al., [2017](#ajmga61324-bib-0053){ref-type="ref"}), asenapine (Borders et al., [2017](#ajmga61324-bib-0010){ref-type="ref"}) olanzapine (Boot, Butcher, van Amelsvoort, et al., [2015](#ajmga61324-bib-0009){ref-type="ref"}; Perret et al., [2017](#ajmga61324-bib-0053){ref-type="ref"}), and quetiapine (Boot, Butcher, van Amelsvoort, et al., [2015](#ajmga61324-bib-0009){ref-type="ref"}).

3.2. Seizures {#ajmga61324-sec-0007}
-------------

Seizures were reported after the start of quetiapine (Boot, Butcher, van Amelsvoort, et al., [2015](#ajmga61324-bib-0009){ref-type="ref"}), aripiprazole (Boot, Butcher, van Amelsvoort, et al., [2015](#ajmga61324-bib-0009){ref-type="ref"}), risperidone (Kook et al., [2010](#ajmga61324-bib-0038){ref-type="ref"}), and clozapine (Aksu & Demirkaya, [2016](#ajmga61324-bib-0001){ref-type="ref"}; Boot et al., [2015](#ajmga61324-bib-0007){ref-type="ref"}; Briegel, [2007](#ajmga61324-bib-0011){ref-type="ref"}; Gladston & Clarke, [2005](#ajmga61324-bib-0029){ref-type="ref"}; Krahn et al., [1998](#ajmga61324-bib-0039){ref-type="ref"}; Yacoub & Aybar, [2007](#ajmga61324-bib-0068){ref-type="ref"}) in individuals with 22q11.2DS. In a retrospective study that looked at the response profile to clozapine, eight of the 20 (44.4%) adults with 22q11.2DS experienced seizures, where patients in the idiopathic psychosis group (*n* = 20) experienced none (Butcher, Fung, Fitzpatrick, Guna, Andrade, Lang, & Chow, [2015](#ajmga61324-bib-0014){ref-type="ref"}). Out of the 17 case reports of individuals treated with clozapine that fulfilled inclusion criteria for this review, five cases (29.4%) reported tonic--clonic seizures (Aksu & Demirkaya, [2016](#ajmga61324-bib-0001){ref-type="ref"}; Boot, Butcher, Vorstman, et al., [2015](#ajmga61324-bib-0007){ref-type="ref"}; Briegel, [2007](#ajmga61324-bib-0011){ref-type="ref"}; Krahn et al., [1998](#ajmga61324-bib-0039){ref-type="ref"}; Yacoub & Aybar, [2007](#ajmga61324-bib-0068){ref-type="ref"}). In a retrospective chart review study in 202 adults with 22q11.2DS it was found that 21 of the 119 patients (17.6%) on psychotropic drugs experienced one or more seizures, and 16 patients (50% of the patients with seizures) experienced their first seizure while taking an antipsychotic (Wither, MacDonald, Borlot, et al., 2017). The antipsychotic most commonly associated with seizures was clozapine Wither, Borlot, MacDonald, et al., 2017.

3.3. Weight gain {#ajmga61324-sec-0008}
----------------

Weight gain was mostly reported in patients that use risperidone (Borders et al., [2017](#ajmga61324-bib-0010){ref-type="ref"}), quetiapine (Starling & Harris, [2008](#ajmga61324-bib-0062){ref-type="ref"}), olanzapine (Faedda et al., [2015](#ajmga61324-bib-0023){ref-type="ref"}; Perret et al., [2017](#ajmga61324-bib-0053){ref-type="ref"}; Starling & Harris, [2008](#ajmga61324-bib-0062){ref-type="ref"}), and clozapine (Gagliano & Masi, [2009](#ajmga61324-bib-0028){ref-type="ref"}). Weight gain was the second most frequent adverse effect reported in five (14.2%) out of the 35 trials with risperidone, quetiapine, and olanzapine (Dori et al., [2017](#ajmga61324-bib-0021){ref-type="ref"}). In a study in 207 adults with 22q11.2DS, it was found that psychotropic medication use, including but not exclusively antipsychotics, increased the odds of developing obesity with \~2.5 times relative to those without psychotropic medication (Voll et al., [2017](#ajmga61324-bib-0065){ref-type="ref"}).

3.4. Cardiac adverse effects {#ajmga61324-sec-0009}
----------------------------

Two cases of clozapine‐induced myocarditis, expected to occur in \~3% of patients on clozapine in general (Ronaldson, Fitzgerald, & McNeil, [2015](#ajmga61324-bib-0055){ref-type="ref"}), have been reported in patients with 22q11.2DS (Boot, Butcher, Vorstman, et al., [2015](#ajmga61324-bib-0007){ref-type="ref"}; Ruhe et al., [2018](#ajmga61324-bib-0056){ref-type="ref"}). In addition, one case report described the development of QT prolongation after sertraline was added to treatment with quetiapine and risperidone, which normalized after discontinuation of sertraline (Dori et al., [2017](#ajmga61324-bib-0021){ref-type="ref"}).

3.5. Cytopenias {#ajmga61324-sec-0010}
---------------

In a retrospective study that looked at the response profile to clozapine, three (15%) of the 20 patients presented with severe neutropenia, while no neutropenia was seen in the patients with idiopathic psychosis (Butcher, Fung, Fitzpatrick, Guna, Andrade, Lang, & Chow, [2015](#ajmga61324-bib-0014){ref-type="ref"}). Neutropenia associated with clozapine use was also reported in two case reports (Gagliano & Masi, [2009](#ajmga61324-bib-0028){ref-type="ref"}; Le Page, [2006](#ajmga61324-bib-0041){ref-type="ref"}), in one case leading to agranulocytosis (Le Page, [2006](#ajmga61324-bib-0041){ref-type="ref"}). It must be noted that the child (aged 7 years) described in the first case report (Gagliano & Masi, [2009](#ajmga61324-bib-0028){ref-type="ref"}) also used aripiprazole and tamoxifen; neutropenia has been reported as a side effect of both drugs in patients without 22q11.2DS (Felin, Naveed, & Chaudhary, [2018](#ajmga61324-bib-0025){ref-type="ref"}; Miké, Currie, & Gee, [1994](#ajmga61324-bib-0043){ref-type="ref"}). Leukopenia was reported with the use of olanzapine monotherapy and clozapine monotherapy (Engebretsen et al., [2015](#ajmga61324-bib-0022){ref-type="ref"}). Thrombocytopenia has been reported in many patients that used clozapine (Farrell et al., [2018](#ajmga61324-bib-0024){ref-type="ref"}; Praharaj & Sarkar, [2010](#ajmga61324-bib-0054){ref-type="ref"}), risperidone (Farrell et al., [2018](#ajmga61324-bib-0024){ref-type="ref"}), haloperidol (Le Page, [2006](#ajmga61324-bib-0041){ref-type="ref"}), olanzapine (Farrell et al., [2018](#ajmga61324-bib-0024){ref-type="ref"}; O\'Hanlon et al., [2003](#ajmga61324-bib-0051){ref-type="ref"}; Praharaj & Sarkar, [2010](#ajmga61324-bib-0054){ref-type="ref"}), and perphenazine (Farrell et al., [2018](#ajmga61324-bib-0024){ref-type="ref"}).

3.6. Critical appraisal {#ajmga61324-sec-0011}
-----------------------

The quality of the trials, cross‐sectional and cohort studies (see [Table S2](#ajmga61324-supitem-0001){ref-type="supplementary-material"}) was highly variable. Most studies were retrospective in nature, and patients and assessors were not blinded to either treatment or outcome. Study objectives differed among the included studies; assessing the safety and tolerability of antipsychotics was not the main objective for all studies. Furthermore, most studies did not apply corrections for possible confounders, and patient selection was mostly unclear. It is noted that some studies reported on partly overlapping cohorts, therefore we combined those references in our results section (see Table [1](#ajmga61324-tbl-0001){ref-type="table"}).

Critical appraisal of the case reports is described in [Table S3](#ajmga61324-supitem-0001){ref-type="supplementary-material"}. It is noted that only two out of 30 case reports performed a challenge--rechallenge approach. Also, dose--response relations were scarcely reported (*n* = 4). Most case reports did not assess the possibility of alternative causes for the reported symptoms. These aspects are essential in determining the likelihood of a causal relation between symptoms and medication use. Therefore, the evidence derived from the case reports remains inconclusive.

4. DISCUSSION {#ajmga61324-sec-0012}
=============

This study is the first to provide a systematic overview of the literature specifically on reported adverse effects of antipsychotic medication in patients with a 22q11.2DS. Symptoms that were reported as (possible) adverse effects were movement disorders, seizures, weight change, cardiac side effects and cytopenias. These symptoms are also known adverse effects of antipsychotics in the nondeleted (general) population. While there is an abundance of case reports, research to this date is merely observational in nature and randomized and/or controlled trials are lacking.

The only study that directly compared the tolerability to antipsychotics in adults with 22q11.2DS to patients without a 22q11.2 deletion (Butcher, Fung, Fitzpatrick, Guna, Andrade, Lang, & Chow, [2015](#ajmga61324-bib-0014){ref-type="ref"}) reported that half of the 22q11.2DS group (*n* = 10, 50%) experienced at least one serious adverse event under treatment with clozapine compared with none of the idiopathic group (gender‐adjusted OR = 16.5, 95% CI 1.8--149.8). Reported adverse events included myocarditis (*n* = 1, 5%), severe neutropenia (*n* = 3, 15%) and seizures (*n* = 8, 40%). However, in this retrospective study, no challenge--rechallenge or dose--response effects were reported.

Our findings are consistent with a recent review that examined effectiveness and side effects of psychiatric medication in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders (Mosheva, Korotkin, Gur, Weizman, & Gothelf, [2019](#ajmga61324-bib-0046){ref-type="ref"}). The authors concluded that individuals with 22q11.2DS and psychiatric disorders are treated in a manner that is similar to those without 22q11.2DS but that comorbid disorders common in 22q11.2DS may complicate treatment to some extent (Mosheva et al., [2019](#ajmga61324-bib-0046){ref-type="ref"}).

In fact, most of the events that were reported as adverse effects are, or may be, common manifestations of 22q11.2DS, even in the absence of antipsychotic medication. Therefore, if and to what extent, the use of antipsychotics was responsible for the observed symptoms could not be established. For example, parkinsonism may not be uncommon in adults with 22q11.2DS (Boot, Butcher, van Amelsvoort, et al., [2015](#ajmga61324-bib-0009){ref-type="ref"}; Butcher et al., [2017](#ajmga61324-bib-0017){ref-type="ref"}). Notably, individuals with 22q11.2DS have an increased risk of developing early‐onset Parkinson\'s disease, with an average age at onset around age 40 years (Boot et al., [2018](#ajmga61324-bib-0008){ref-type="ref"}; Butcher, Kiehl, Hazrati, et al., 2013). It is therefore important to differentiate between antipsychotic medication‐induced extrapyramidal adverse effects and Parkinson\'s disease in this population. Dopamine transporter (DAT) imaging may be helpful in this (Booij, van Amelsvoort, & Boot, [2010](#ajmga61324-bib-0006){ref-type="ref"}).

Furthermore, seizures and epilepsy, are more prevalent in individuals with 22q11.2DS than in the general population (Wither et al., 2017), and anticonvulsant treatment may be necessary (Wither et al., 2017), especially in those patients on clozapine (Butcher et al., 2015). In addition to hypocalcemia, antipsychotic medication, in particular clozapine, is an important contributor to a lowered seizure threshold in adults with 22q11.2DS that should alert clinicians (Wither et al., 2017).

Weight gain and metabolic syndrome are well‐known adverse events of antipsychotic medication (Allison & Casey, [2001](#ajmga61324-bib-0002){ref-type="ref"}; Newcomer, [2007](#ajmga61324-bib-0049){ref-type="ref"}). No studies assessed whether patients with 22q11.2DS have an increased risk compared to other populations. However, in a study in adults with 22q11.2DS, it was found that psychotropic medication use, including but not exclusively antipsychotics, increased the odds of developing obesity with \~2.5 times (Voll et al., [2017](#ajmga61324-bib-0065){ref-type="ref"}). Given the comorbidity in 22q11.2DS, such as congenital heart defects, the observed risk of developing obesity during antipsychotic treatment may also warrant extra attention.

Thrombocytopenia was reported in several patients on antipsychotic medication. However, thrombocytopenia is a common manifestations of 22q11.2DS (Bassett et al., [2011](#ajmga61324-bib-0004){ref-type="ref"}), and patients with 22q11.2DS typically have reduced platelet counts that usually do not require specific precautions (Lawrence, McDonald‐McGinn, Zackai, & Sullivan, [2003](#ajmga61324-bib-0040){ref-type="ref"}). A low white blood cell count was also frequently seen, including 15% (3 out of 20) of the patients on clozapine in the study by Butcher et al. (2015), above general population expectations (Schulte, [2006](#ajmga61324-bib-0061){ref-type="ref"}).

Given the increased prevalence of physical health problems in 22q11.2DS additional safety measures are recommended to prevent and monitor side effects and the occurrence of serious adverse events, see Box [1](#ajmga61324-fea-0001){ref-type="boxed-text"} for more information.

###### Recommendations for prescribing antipsychotic medication in 22q11.2DS

 {#ajmga61324-sec-0013}

As patients with 22q11.2DS may be at increased risk for movement disorders, a motor assessment should be part of standard clinical practice.Be aware that patients with 22q11.2DS are at increased risk for developing early‐onset Parkinson\'s disease, with mean age at onset for motor signs relatively young at approximately 40 years. Molecular imaging may be helpful to distinguish Parkinson\'s disease from antipsychotic medication‐induced parkinsonism.As most antipsychotic medications lower seizure threshold (particularly with clozapine), and 22q11.2DS is associated with hypocalcemic seizures, frequent monitoring of calcium levels is warranted.To reduce seizure risk, consider the addition of low‐dose anticonvulsant when clozapine is initiated.Consider to consult a neurologist in case of, nonhypocalcemic, seizures.Promote daily exercise and a healthy diet to prevent weight gain during antipsychotic treatment.In general, it is recommended to monitor calcium levels, thyroid function and platelets on a regular basis, and to follow general management recommendations for adults with 22q11.2DS (Fung et al., [2015](#ajmga61324-bib-0026){ref-type="ref"}).

It is important to note that 50% of the case studies reported on clozapine use in 22q11.2DS, and this is much higher than expected (Nielsen, Røge, Schjerning, Sørensen, & Taylor, [2012](#ajmga61324-bib-0050){ref-type="ref"}) given that clozapine is usually prescribed for treatment‐resistant schizophrenia. This may indicate a publication bias in the included case reports; as of yet, there is no evidence for increased prevalence of treatment‐resistant schizophrenia in 22q11.2DS. It has been suggested that regular antipsychotics may have limited effect in 22q11.2DS (Verhoeven & Egger, [2015](#ajmga61324-bib-0064){ref-type="ref"}) but to the best of our knowledge, there are no randomized controlled trials supporting this hypothesis. It is likely, however, that clozapine is prescribed more often to patients with 22q11.2DS given that clozapine is less likely than other antipsychotic medications to cause motor side effects (Casey, [1989](#ajmga61324-bib-0018){ref-type="ref"}; Rummel‐Kluge et al., [2010](#ajmga61324-bib-0057){ref-type="ref"}). Given the multisystem nature of the condition, and the increased prevalence of physical health problems in 22q11.2DS, extra attention is recommended to prevent and monitor the occurrence of (serious) adverse events, see Box [1](#ajmga61324-fea-0001){ref-type="boxed-text"} for more information.

5. CONCLUSION {#ajmga61324-sec-0014}
=============

Most of the reported adverse effects in this systematic review; movement disorders, seizures, weight change, cardiac side effects, leukopenia and thrombocytopenia, are common manifestations in individuals with 22q11.2DS, even in the absence of antipsychotic medication. Also, the reported adverse effects in 22q11.2DS are mostly similar to common side effects of antipsychotic medication observed in the nondeleted (general) population. Based on the existing literature, a causal relation between antipsychotic medication and the reported adverse effects could not be established. Randomized clinical trials are needed to make firm conclusions regarding risk of adverse effects of antipsychotics in people with 22q11.2DS. In conclusion, when considering antipsychotic medication in patients with 22q11.2DS, clinicians need to balance potential risks and benefits, and monitor patients regularly to screen for side effects.
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